Cancer Immunotherapy Animation
Scientific Animation | Corporate Communications and Visual Continuity
Gradalis’ Vigil® Platform is a fully personalized, patient-specific cancer immunotherapy. The Vigil® Platform is indicated for patients with advanced solid tumors and is currently being developed for the treatment of ovarian cancer and breast cancer. The Vigil® Platform uses the patient’s cancer cells to create a personalized cancer immunotherapy that activates the patient’s own T-cells to fight their cancer cells.